Retained products of conception
- Daniela A Carusi, MD, MSc
Daniela A Carusi, MD, MSc
- Assistant Professor of Obstetrics & Gynecology
- Harvard Medical School
The term retained products of conception (RPOC) refers to placental and/or fetal tissue that remains in the uterus after a spontaneous pregnancy loss (miscarriage), planned pregnancy termination, or preterm/term delivery. The presence of RPOC after a spontaneous pregnancy loss distinguishes an incomplete from a complete miscarriage.
This topic will review the evaluation and management of women who present with bleeding and/or signs of infection after uterine evacuation in the first half of pregnancy. Management of RPOC after preterm/term delivery and the initial management of an incomplete miscarriage are discussed separately. (See "Overview of postpartum hemorrhage" and "Postpartum endometritis" and "Spontaneous abortion: Management".)
The reported incidence of RPOC varies widely and depends on several factors, including initial treatment (higher with nonsurgical versus surgical management), criteria for diagnosis (signs/symptoms versus laboratory/pathology/imaging results), and duration of follow-up (RPOC often resorb or are passed) [1-17].
The characteristic clinical manifestations of RPOC include one or more of the following: uterine bleeding, pelvic pain, fever, and/or uterine tenderness. These clinical findings are nonspecific; moreover, it is normal to have some postabortal bleeding and discomfort.
Uterine bleeding — Women routinely have some uterine bleeding after a miscarriage or pregnancy termination, so it can be difficult to distinguish normal from abnormal bleeding. A reasonable approach is to assume that bleeding is probably abnormal if it is heavy (ie, has the potential to result in anemia [passage of large clots or flow that is significantly greater than menses, or not diminishing over time]) or prolonged (ie, lasting longer than three weeks).
Subscribers log in hereLiterature review current through: Jul 2017. | This topic last updated: Jan 26, 2016.References
- Trinder J, Brocklehurst P, Porter R, et al. Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ 2006; 332:1235.
- Maslovitz S, Almog B, Mimouni GS, et al. Accuracy of diagnosis of retained products of conception after dilation and evacuation. J Ultrasound Med 2004; 23:749.
- Nielsen S, Hahlin M. Expectant management of first-trimester spontaneous abortion. Lancet 1995; 345:84.
- Bagratee JS, Khullar V, Regan L, et al. A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Hum Reprod 2004; 19:266.
- Herabutya Y, O-Prasertsawat P. Misoprostol in the management of missed abortion. Int J Gynaecol Obstet 1997; 56:263.
- Kovavisarach E, Sathapanachai U. Intravaginal 400 microg misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Aust N Z J Obstet Gynaecol 2002; 42:161.
- Lister MS, Shaffer LE, Bell JG, et al. Randomized, double-blind, placebo-controlled trial of vaginal misoprostol for management of early pregnancy failures. Am J Obstet Gynecol 2005; 193:1338.
- Wood SL, Brain PH. Medical management of missed abortion: a randomized clinical trial. Obstet Gynecol 2002; 99:563.
- Ngai SW, Chan YM, Tang OS, Ho PC. Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Hum Reprod 2001; 16:1493.
- Luise C, Jermy K, Collons WP, Bourne TH. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol 2002; 19:580.
- Sotiriadis A, Makrydimas G, Papatheodorou S, Ioannidis JP. Expectant, medical, or surgical management of first-trimester miscarriage: a meta-analysis. Obstet Gynecol 2005; 105:1104.
- Demetroulis C, Saridogan E, Kunde D, Naftalin AA. A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Hum Reprod 2001; 16:365.
- Muffley PE, Stitely ML, Gherman RB. Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. Am J Obstet Gynecol 2002; 187:321.
- Zhang J, Gilles JM, Barnhart K, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 2005; 353:761.
- Thonneau P, Fougeyrollas B, Ducot B, et al. Complications of abortion performed under local anesthesia. Eur J Obstet Gynecol Reprod Biol 1998; 81:59.
- Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of first-trimester abortion: a report of 170,000 cases. Obstet Gynecol 1990; 76:129.
- Christin-Maitre S, Bouchard P, Spitz IM. Medical termination of pregnancy. N Engl J Med 2000; 342:946.
- Davis AR, Hendlish SK, Westhoff C, et al. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. Am J Obstet Gynecol 2007; 196:31.e1.
- Cohen AL, Bhatnagar J, Reagan S, et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and spontaneous abortion. Obstet Gynecol 2007; 110:1027.
- Fischer M, Bhatnagar J, Guarner J, et al. Fatal toxic shock syndrome associated with Clostridium sordellii after medical abortion. N Engl J Med 2005; 353:2352.
- Wolman I, Altman E, Faith G, et al. Combined clinical and ultrasonographic work-up for the diagnosis of retained products of conception. Fertil Steril 2009; 92:1162.
- Barnhart K, Sammel MD, Chung K, et al. Decline of serum human chorionic gonadotropin and spontaneous complete abortion: defining the normal curve. Obstet Gynecol 2004; 104:975.
- Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol 2003; 109:190.
- McEwing RL, Anderson NG, Meates JB, et al. Sonographic appearances of the endometrium after termination of pregnancy in asymptomatic versus symptomatic women. J Ultrasound Med 2009; 28:579.
- Ben-Ami I, Schneider D, Maymon R, et al. Sonographic versus clinical evaluation as predictors of residual trophoblastic tissue. Hum Reprod 2005; 20:1107.
- Abbasi S, Jamal A, Eslamian L, Marsousi V. Role of clinical and ultrasound findings in the diagnosis of retained products of conception. Ultrasound Obstet Gynecol 2008; 32:704.
- Sawyer E, Ofuasia E, Ofili-Yebovi D, et al. The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. Ultrasound Obstet Gynecol 2007; 29:205.
- van den Bosch T, Daemen A, Van Schoubroeck D, et al. Occurrence and outcome of residual trophoblastic tissue: a prospective study. J Ultrasound Med 2008; 27:357.
- Halperin R, Schneider D, Maymon R, et al. Arteriovenous malformation after uterine curettage: a report of 3 cases. J Reprod Med 2007; 52:445.
- Cura M, Martinez N, Cura A, et al. Arteriovenous malformations of the uterus. Acta Radiol 2009; 50:823.
- Rufener SL, Adusumilli S, Weadock WJ, Caoili E. Sonography of uterine abnormalities in postpartum and postabortion patients: a potential pitfall of interpretation. J Ultrasound Med 2008; 27:343.
- Jain K, Fogata M. Retained products of conception mimicking a large endometrial AVM: complete resolution following spontaneous abortion. J Clin Ultrasound 2007; 35:42.
- Betel C, Atri M, Arenson AM, et al. Sonographic diagnosis of gestational trophoblastic disease and comparison with retained products of conception. J Ultrasound Med 2006; 25:985.
- Keogan MT, Hertzberg BS, Kliewer MA. Low resistance Doppler waveforms with retained products of conception: potential for diagnostic confusion with gestational trophoblastic disease. Eur J Radiol 1995; 21:109.
- Alcázar JL. Transvaginal ultrasonography combined with color velocity imaging and pulsed Doppler to detect residual trophoblastic tissue. Ultrasound Obstet Gynecol 1998; 11:54.
- Durfee SM, Frates MC, Luong A, Benson CB. The sonographic and color Doppler features of retained products of conception. J Ultrasound Med 2005; 24:1181.
- Alcázar JL, Ortiz CA. Transvaginal color Doppler ultrasonography in the management of first-trimester spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 2002; 102:83.
- Müngen E, Dundar O, Babacan A. Postabortion Doppler evaluation of the uterus: incidence and causes of myometrial hypervascularity. J Ultrasound Med 2009; 28:1053.
- Wong SF, Lam MH, Ho LC. Transvaginal sonography in the detection of retained products of conception after first-trimester spontaneous abortion. J Clin Ultrasound 2002; 30:428.
- Creinin MD, Harwood B, Guido RS, et al. Endometrial thickness after misoprostol use for early pregnancy failure. Int J Gynaecol Obstet 2004; 86:22.
- Reeves MF, Lohr PA, Harwood BJ, Creinin MD. Ultrasonographic endometrial thickness after medical and surgical management of early pregnancy failure. Obstet Gynecol 2008; 111:106.
- Bar-Hava I, Aschkenazi S, Orvieto R, et al. Spectrum of normal intrauterine cavity sonographic findings after first-trimester abortion. J Ultrasound Med 2001; 20:1277.
- Wolman I, Jaffa AJ, Pauzner D, et al. Transvaginal sonohysterography: a new aid in the diagnosis of residual trophoblastic tissue. J Clin Ultrasound 1996; 24:257.
- Rein DT, Schmidt T, Hess AP, et al. Hysteroscopic management of residual trophoblastic tissue is superior to ultrasound-guided curettage. J Minim Invasive Gynecol 2011; 18:774.
- Hamerlynck TW, Blikkendaal MD, Schoot BC, et al. An alternative approach for removal of placental remnants: hysteroscopic morcellation. J Minim Invasive Gynecol 2013; 20:796.
- Prieto JA, Eriksen NL, Blanco JD. A randomized trial of prophylactic doxycycline for curettage in incomplete abortion. Obstet Gynecol 1995; 85:692.
- Seeras R. Evaluation of prophylactic use of tetracycline after evacuation in abortion in Harare Central Hospital. East Afr Med J 1989; 66:607.
- Al-Inany H. Intrauterine adhesions. An update. Acta Obstet Gynecol Scand 2001; 80:986.
- Schenker JG. Etiology of and therapeutic approach to synechia uteri. Eur J Obstet Gynecol Reprod Biol 1996; 65:109.
- Friedler S, Margalioth EJ, Kafka I, Yaffe H. Incidence of post-abortion intra-uterine adhesions evaluated by hysteroscopy--a prospective study. Hum Reprod 1993; 8:442.
- Westendorp IC, Ankum WM, Mol BW, Vonk J. Prevalence of Asherman's syndrome after secondary removal of placental remnants or a repeat curettage for incomplete abortion. Hum Reprod 1998; 13:3347.
- Ben-Ami I, Ofir T, Melcer Y, et al. Infertility following retained products of conception: is it the surgical procedure or the presence of trophoblastic tissue? Eur J Obstet Gynecol Reprod Biol 2014; 182:132.
- Klingberg-Allvin M, Cleeve A, Atuhairwe S, et al. Comparison of treatment of incomplete abortion with misoprostol by physicians and midwives at district level in Uganda: a randomised controlled equivalence trial. Lancet 2015; 385:2392.
- Chambers DG, Mulligan EC. Treatment of suction termination of pregnancy-retained products with misoprostol markedly reduces the repeat operation rate. Aust N Z J Obstet Gynaecol 2009; 49:551.
- Nanda K, Peloggia A, Grimes D, et al. Expectant care versus surgical treatment for miscarriage. Cochrane Database Syst Rev 2006; :CD003518.
- Papadakis JC, Christodoulou N, Papageorgiou A, Rasidaki M. Placenta percreta presenting in the first trimester and resulting in severe consumption coagulopathy and hysterectomy: a case report. Clin Exp Obstet Gynecol 2008; 35:225.
- Takeda A, Koyama K, Imoto S, et al. Conservative management of placenta increta after first trimester abortion by transcatheter arterial chemoembolization: a case report and review of the literature. Arch Gynecol Obstet 2010; 281:381.
- Walter AJ, McCullough AE, Patel MD, Cornella JL. Placenta increta presenting as delayed postabortal hemorrhage. Obstet Gynecol 1999; 93:846.
- Soleymani Majd H, Srikantha M, Majumdar S, et al. Successful use of uterine artery embolisation to treat placenta increta in the first trimester. Arch Gynecol Obstet 2009; 279:713.
- Wang YL, Su TH, Huang WC, Weng SS. Laparoscopic management of placenta increta after late first-trimester dilation and evacuation manifesting as an unusual uterine mass. J Minim Invasive Gynecol 2011; 18:250.
- CLINICAL MANIFESTATIONS
- Uterine bleeding
- Fever and/or pain
- DIFFERENTIAL DIAGNOSIS
- DIAGNOSTIC EVALUATION
- Physical examination
- Imaging studies
- - Sonohysterography
- Patients who are hemodynamically unstable
- Patients with sepsis
- Medically stable patients with endometritis
- Medically stable patients with prolonged bleeding
- - Surgical intervention
- - Medical intervention
- - Expectant management
- - Abnormal placentation
- SOCIETY GUIDELINE LINKS
- SUMMARY AND RECOMMENDATIONS